CHEMILUMINESCENCE IMMUNOASSAY FOR CANDIDA ANTIGENS

Award Information
Agency:
Department of Health and Human Services
Amount:
$45,000.00
Program:
SBIR
Contract:
N/A
Solitcitation Year:
N/A
Solicitation Number:
N/A
Branch:
N/A
Award Year:
1987
Phase:
Phase I
Agency Tracking Number:
7108
Solicitation Topic Code:
N/A
Small Business Information
London Diagnostics Inc
10300 Valley View Road, Suite 107, Eden Prairie, MN, 55344
Hubzone Owned:
N
Woman Owned:
N
Socially and Economically Disadvantaged:
N
Duns:
N/A
Principal Investigator
 ASHOK PATEL PHD
 (612) 941-3812
Business Contact
Phone: () -
Research Institution
N/A
Abstract
THE AIM OF THIS PROJECT IS TO DEMONSTRATE AN IMMUNOMETRIC ASSAY FOR CANDIDA ANTIGEN (MANNAN) USING ACRIDINIUM ESTERS AS A CHEMILUMINESCENT LABEL. THIS WILL LEAD TO A TECHNIQUE FOR THE DETECTION OF FUNGAL ANTIGENS THAT REQUIRES HIGH SENSITIVITY, BY A METHOD THAT IS SIMPLER, SAFER, AND CHEAPERTHAN CONVENTIONAL METHODS. MONOCLONAL ANTIBODIES TO CANDIDA MANNAN WILL BE PURIFIED AND CHARACTERIZED FOR THEIR USEFULNESS IN IMMUNOASSAYS. THEY WILL BE COVALENTLY LABELED WITH AN ACRIDINIUM ESTER TO A HIGH SPECIFIC ACTIVITY AND USED TO DEVELOP A SENSITIVE CHEMILUMINESCENCE ASSAY. THE ASSAY WILL BE OPTIMIZED AND COMPARED TO CURRENT METHODS. THE RESEARCH SHOULD PROVIDE AN ASSAY FOR SYSTEMIC CANDIDA INFECTION USING STABLE REAGENTS. THE ASSAY WILL DEMONSTRATE HIGH SPECIFICITY OBTAINED BY USING MONOCLONAL ANTIBODIES AND SENSITIVITY FROM THE CHEMILUMINESCENCE TECHNIQUE. THIS WILL LEAD TO PHASE II RESEARCH, DEVELOPMENT, AND PRODUCTION OF A COMMERCIAL CLINICAL TRIALS. CHEMILUMINESCENCE ASSAY, PROTOTYPE INSTRUMENT DESIGN AND TO

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government